Clinical Domain Certificate
Metabolism and Weight Management
Incretin biology, metabolic syndrome and emerging metabolic therapies
A focused certificate exploring obesity, metabolic syndrome, insulin resistance, incretin biology and emerging metabolic therapies through current scientific evidence and clinical reasoning.
About this programme
Each Clinical Domain Certificate examines a specific area of clinical practice through current scientific evidence, biological mechanisms and structured clinical reasoning. The certificate begins with a dedicated introductory gateway module before progressing into domain-specific content.
Learning objectives
- Describe the physiology of energy balance and weight regulation.
- Interpret current evidence for incretin-based therapies.
- Appraise published trials of emerging metabolic agents.
- Apply governance principles when discussing non-authorised compounds.
- Communicate metabolic risk and treatment uncertainty to patients.
Programme outline
- Energy balance and the biology of obesity
- Insulin resistance and the metabolic syndrome
- Incretin biology (GLP-1, GIP) and downstream signalling
- Authorised and emerging metabolic therapies — critical appraisal
- Cardiometabolic risk assessment
- Long-term safety, governance and patient selection
Format
Online modular learning, gateway module plus domain content, structured assessment.
Audience
Qualified healthcare practitioners working in or adjacent to metabolic medicine.
Prerequisites
Completion of Introduction to Peptides in Health and Disease, or equivalent.
Dates & pricing
Enrolment dates, fees and admissions criteria will be published in due course. To register interest, please return once a formal contact channel has been announced.